Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00213-008-1300-y.

Title:
Antidepressant activity of curcumin: involvement of serotonin and dopamine system | Psychopharmacology
Description:
Rationale Curcumin is a major active principle of Curcuma longa, one of the widely used preparations in the Indian system of medicine. It is known for its diverse biological actions. Objective The present study was designed to investigate the involvement of monoaminergic system(s) in the antidepressant activity of curcumin and the effect of piperine, a bioavailability enhancer, on the bioavailability and biological effects of curcumin. Methods and observations Behavioral (forced swim test), biochemical (monoamine oxidase (MAO) enzyme inhibitory activity), and neurochemical (neurotransmitter levels estimation) tests were carried out. Curcumin (10–80 mg/kg, i.p.) dose dependently inhibited the immobility period, increased serotonin (5-hydroxytryptamine, 5-HT) as well as dopamine levels (at higher doses), and inhibited the monoamine oxidase enzymes (both MAO-A and MAO-B, higher doses) in mice. Curcumin (20 mg/kg, i.p.) enhanced the anti-immobility effect of subthreshold doses of various antidepressant drugs like fluoxetine, venlafaxine, or bupropion. However, no significant change in the anti-immobility effect of imipramine and desipramine was observed. Furthermore, combination of subthreshold dose of curcumin and various antidepressant drugs resulted in synergistic increase in serotonin (5-HT) levels as compared to their effect per se. There was no change in the norepinephrine levels. The coadministration of piperine (2.5 mg/kg, i.p.), a bioavailability enhancing agent, with curcumin (20 and 40 mg/kg, i.p.) resulted in potentiation of pharmacological, biochemical, and neurochemical activities. Conclusion The study provides evidences for mechanism-based antidepressant actions of curcumin. The coadministration of curcumin along with piperine may prove to be a useful and potent natural antidepressant approach in the management of depression.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Social Networks
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

article, google, scholar, cas, curcumin, pubmed, antidepressant, effect, pharmacol, kulkarni, med, activity, serotonin, effects, access, privacy, cookies, content, psychopharmacology, dopamine, study, piperine, oxidase, levels, mice, biochem, res, publish, search, involvement, shrinivas, indian, bioavailability, forced, test, biochemical, monoamine, mgkg, doses, depression, planta, eur, university, data, information, change, log, journal, research, system,

Topics {✒️}

month download article/chapter mechanism-based antidepressant actions purine nucleoside-mediated immobility ethanol withdrawal-induced behavioural kulkarni & mahendra bishnoi article psychopharmacology aims full article pdf forced swim test forced swimming test privacy choices/manage cookies major active principle related subjects experimentally induced diabetes european economic area diverse biological actions stress axis reactivity anti-tumour promoter anti-inflammatory agent areca catechu nut ruffin mt 4th olfactory bulbactomy models monoamine oxidase enzymes mitochondrial monoamine oxidase dopamine reuptake inhibitor enzyme inhibitory activity conditions privacy policy antidepressant drugs resulted rat frontal cortex article kulkarni accepting optional cookies ischaemia-induced biochemical neurotransmitter levels estimation bioavailability enhancing agent nitric oxide synthase antidepressant action article log anti-immobility effect vivo microdialysis study curcuma longa rhizomes author information authors serotonin monoamine oxidase dose dependently inhibited journal finder publish biochemical studies article cite antidepressant activity check access instant access diabetic albino rats antidepressant drugs

Questions {❓}

  • How does curcumin work with poor bioavailability?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Antidepressant activity of curcumin: involvement of serotonin and dopamine system
         description:Curcumin is a major active principle of Curcuma longa, one of the widely used preparations in the Indian system of medicine. It is known for its diverse biological actions. The present study was designed to investigate the involvement of monoaminergic system(s) in the antidepressant activity of curcumin and the effect of piperine, a bioavailability enhancer, on the bioavailability and biological effects of curcumin. Behavioral (forced swim test), biochemical (monoamine oxidase (MAO) enzyme inhibitory activity), and neurochemical (neurotransmitter levels estimation) tests were carried out. Curcumin (10–80 mg/kg, i.p.) dose dependently inhibited the immobility period, increased serotonin (5-hydroxytryptamine, 5-HT) as well as dopamine levels (at higher doses), and inhibited the monoamine oxidase enzymes (both MAO-A and MAO-B, higher doses) in mice. Curcumin (20 mg/kg, i.p.) enhanced the anti-immobility effect of subthreshold doses of various antidepressant drugs like fluoxetine, venlafaxine, or bupropion. However, no significant change in the anti-immobility effect of imipramine and desipramine was observed. Furthermore, combination of subthreshold dose of curcumin and various antidepressant drugs resulted in synergistic increase in serotonin (5-HT) levels as compared to their effect per se. There was no change in the norepinephrine levels. The coadministration of piperine (2.5 mg/kg, i.p.), a bioavailability enhancing agent, with curcumin (20 and 40 mg/kg, i.p.) resulted in potentiation of pharmacological, biochemical, and neurochemical activities. The study provides evidences for mechanism-based antidepressant actions of curcumin. The coadministration of curcumin along with piperine may prove to be a useful and potent natural antidepressant approach in the management of depression.
         datePublished:2008-09-03T00:00:00Z
         dateModified:2008-09-03T00:00:00Z
         pageStart:435
         pageEnd:442
         sameAs:https://doi.org/10.1007/s00213-008-1300-y
         keywords:
            Curcumin
            Forced swim test (FST)
            Serotonin
            Monoamine oxidase (MAO)
            Piperine
            Neurosciences
            Pharmacology/Toxicology
            Psychiatry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig5_HTML.gif
         isPartOf:
            name:Psychopharmacology
            issn:
               1432-2072
               0033-3158
            volumeNumber:201
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shrinivas K. Kulkarni
               affiliation:
                     name:Panjab University
                     address:
                        name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
                        type:PostalAddress
                     type:Organization
                     name:Panjab University
                     address:
                        name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Mohit Kumar Bhutani
               affiliation:
                     name:Panjab University
                     address:
                        name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mahendra Bishnoi
               affiliation:
                     name:Panjab University
                     address:
                        name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Antidepressant activity of curcumin: involvement of serotonin and dopamine system
      description:Curcumin is a major active principle of Curcuma longa, one of the widely used preparations in the Indian system of medicine. It is known for its diverse biological actions. The present study was designed to investigate the involvement of monoaminergic system(s) in the antidepressant activity of curcumin and the effect of piperine, a bioavailability enhancer, on the bioavailability and biological effects of curcumin. Behavioral (forced swim test), biochemical (monoamine oxidase (MAO) enzyme inhibitory activity), and neurochemical (neurotransmitter levels estimation) tests were carried out. Curcumin (10–80 mg/kg, i.p.) dose dependently inhibited the immobility period, increased serotonin (5-hydroxytryptamine, 5-HT) as well as dopamine levels (at higher doses), and inhibited the monoamine oxidase enzymes (both MAO-A and MAO-B, higher doses) in mice. Curcumin (20 mg/kg, i.p.) enhanced the anti-immobility effect of subthreshold doses of various antidepressant drugs like fluoxetine, venlafaxine, or bupropion. However, no significant change in the anti-immobility effect of imipramine and desipramine was observed. Furthermore, combination of subthreshold dose of curcumin and various antidepressant drugs resulted in synergistic increase in serotonin (5-HT) levels as compared to their effect per se. There was no change in the norepinephrine levels. The coadministration of piperine (2.5 mg/kg, i.p.), a bioavailability enhancing agent, with curcumin (20 and 40 mg/kg, i.p.) resulted in potentiation of pharmacological, biochemical, and neurochemical activities. The study provides evidences for mechanism-based antidepressant actions of curcumin. The coadministration of curcumin along with piperine may prove to be a useful and potent natural antidepressant approach in the management of depression.
      datePublished:2008-09-03T00:00:00Z
      dateModified:2008-09-03T00:00:00Z
      pageStart:435
      pageEnd:442
      sameAs:https://doi.org/10.1007/s00213-008-1300-y
      keywords:
         Curcumin
         Forced swim test (FST)
         Serotonin
         Monoamine oxidase (MAO)
         Piperine
         Neurosciences
         Pharmacology/Toxicology
         Psychiatry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00213-008-1300-y/MediaObjects/213_2008_1300_Fig5_HTML.gif
      isPartOf:
         name:Psychopharmacology
         issn:
            1432-2072
            0033-3158
         volumeNumber:201
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shrinivas K. Kulkarni
            affiliation:
                  name:Panjab University
                  address:
                     name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
                     type:PostalAddress
                  type:Organization
                  name:Panjab University
                  address:
                     name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Mohit Kumar Bhutani
            affiliation:
                  name:Panjab University
                  address:
                     name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mahendra Bishnoi
            affiliation:
                  name:Panjab University
                  address:
                     name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Psychopharmacology
      issn:
         1432-2072
         0033-3158
      volumeNumber:201
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Panjab University
      address:
         name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
         type:PostalAddress
      name:Panjab University
      address:
         name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
         type:PostalAddress
      name:Panjab University
      address:
         name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
         type:PostalAddress
      name:Panjab University
      address:
         name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shrinivas K. Kulkarni
      affiliation:
            name:Panjab University
            address:
               name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
               type:PostalAddress
            type:Organization
            name:Panjab University
            address:
               name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Mohit Kumar Bhutani
      affiliation:
            name:Panjab University
            address:
               name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
               type:PostalAddress
            type:Organization
      name:Mahendra Bishnoi
      affiliation:
            name:Panjab University
            address:
               name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
      name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
      name:Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
      name:Centre with Potential for Excellence in Biomedical Sciences (CPEBS), Panjab University, Chandigarh, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(104)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.41s.